SavedAdd your journal

Journals / Glokom Katarakt / 2014 / Cilt: 9 - Sayı: 2

The Current View to Selective Laser Trabeculoplasty

Selektif Lazer Trabeküloplasti'ye Güncel Bakış

AHMET ELBAY
OSMAN ÇEKİÇ
Pages
150–158
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Ocular pain, transient mild inflammation and severe intraocular pressure elevations immediately afterwards the procedure are the most noted complications of SLT

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Selective laser trabeculoplasty (SLT) is an easy laser method that can be conveniently learned by ophthalmologists because of the larger spot size used in the technique.
📊
Key Findings & Data:It has been demonstrated that SLT is a novel choice to manage intraocular pressure in eyes with several forms of open-angle glaucoma and ocular hypertension and in eyes unresponsive to prior argon laser trabeculoplasty treatment.
💡
Conclusion & Impact:Ocular pain, transient mild inflammation and severe intraocular pressure elevations immediately afterwards the procedure are the most noted complications of SLT
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Selective laser trabeculoplasty (SLT) is an easy laser method that can be conveniently learned by ophthalmologists because of the larger spot size used in the technique. It has been demonstrated that SLT is a novel choice to manage intraocular pressure in eyes with several forms of open-angle glaucoma and ocular hypertension and in eyes unresponsive to prior argon laser trabeculoplasty treatment. Unlike argon laser trabeculoplasty, SLT causes no destruction to the trabecular meshwork because of the use of lower laser energy. This also enables repeatability of the technique. SLT shows equivalent efficacy and similar safety to argon laser trabeculoplasty and topical medical therapy in reducing intraocular pressure. SLT is also being used as a first-line treatment for open angle glaucoma. Additionally, it can be an effective treatment modality among patients who cannot tolerate or comply with classic anti-glaucoma drug therapy. Ocular pain, transient mild inflammation and severe intraocular pressure elevations immediately afterwards the procedure are the most noted complications of SLT

Özet

Selektif lazer trabeküloplasti (SLT), geniş spot büyüklüğü sebebiyle oftalmologlar tarafından kolay öğrenilebilen bir yöntemdir. SLT'nin, açık açılı glokomda, oküler hipertansiyonda ve argon laser trabeküloplastinin etkisinin kaybolduğu hastalarda göz içi basıncını etkin bir şekilde düşürdüğü ve glokom tedavisinde yeni bir seçenek olabileceği gösterilmiştir. Bu yöntemde düşük enerji kullanıldığı için, argon lazer trabeküloplastinin tersine trabeküler ağ yapısında herhangi bir hasar oluşmamaktadır. Bu durum SLT'ye tekrarlanabilir olma imkanını verir. SLT göz içi basıncını düşürme konusunda argon laser trabeküloplasti ve topikal ilaç tedavisi ile eş değer etkinliğe ve benzer güvenilirliğe sahiptir. Ayrıca SLT, açık açılı glokomda ilk tedavi seçeneği olarak da kullanılmaktadır. İlaç kullanımına uyum gösteremeyen ya da ilacı tolere edemeyen hastalarda ise etkili bir ajan olabilir. Oküler ağrı, hafif düzeyde geçici inflamasyon ve işlem sonrası oluşan ciddi göz içi basıncı yükselmesi, SLT'nin en sık görülen komplikasyonlarıdır

🔖

Cite This Article

ELBAY, A., ÇEKİÇ, O. (2014). The Current View to Selective Laser Trabeculoplasty. Glokom Katarakt, Cilt: 9 - Sayı: 2, 150–158. https://ajindex.com/articles/226453

References (17)

  1. Wise IB, Witter SL. Argon laser therapy for open angle glau- coma: a pilot study. Arch Ophthalmol 1979;97:319-26.
  2. Aykan Ü, Iwach AG. Argon lazer trabeküloplasti (ALT) uygulanmış gözlerde selektif lazer trabeküloplasti (SLT) etkinliği. T Oft Gaz 2007;37:187-92. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Glaucoma Laser Trial Research Group. Am J Ophthalmology 1995;120:718-31.
  3. Schwartz K, Budenz D. Current management of glaucoma. Curr Opin Ophthalmol 2004;15:119-126.
  4. McHugh D, Marshall J, Ffytche TJ, et al. A. Diode laser tra- beculoplasty (DLT) for primary open-angle glaucoma. Br J Ophthalmol 1990;74:743-7.
  5. Moriarty AP, McHugh JD, Ffytche TJ, et al. Long-term follow-up of diode laser trabeculoplasty for primary open-angle glaucoma and ocular hypertension. Ophthalmology 1993;100:1614-8.
  6. Brooks AM, Gillies WE. Laser trabeculoplasty--argon or di- ode? Aus N Z J Ophthalmol 1993;21:161-4.
  7. Juzych MS, Chopra V, Bannit MR, et al. Comparison of long- term outcomes of selective laser trabeculoplasty versus ar- gon laser trabeculoplasty in open-angle glaucoma. Ophthal- mology 2004;111:1853-9.
  8. Spiegel D, Wegscheider E, Lund OE. Argon laser trabeculo- plasty: long-term follow-up of at least 5 years. Ger J Ophthal- mol 1992;1:156-8.
  9. Fink A, Jordan AJ, Lao PN, et al. Therapeutic limitations of argon laser trabeculoplasty. Br J Ophthalmol 1988;72:263-9.
  10. Reiss GR, Wilwnsky JT, Higginbotham EJ. Laser trabeculo- plasty. Surv Ophthalmol 1991;35:407-28.
  11. Hoskins HD, Hetherington J, Minckler DS et al. Complica- tons of laser trabeculoplasty Ophthalmology 1983;90:796-803.
  12. Latina M, Park C. Selective targeting of trabecular meshwork cells: In vitro studies of pulsed and CW laser interactions. Exp Eye Res 1995;60:359-72.
  13. Ticho U, Zauberman H. Argon laser application to the angle structures in the glaucomas. Arch Ophthalmol 1976;94:61-4.
  14. Kramer TR, Noecker RJ. Comparison of the morphologic chang- es after selective laser trabeculoplasty and argon laser trabeculo- plasty in human eye bank eyes. Ophthalmology 2001;108:773-9.
  15. Latina MA, Sibayan SA, Shin DH, et al. Q-switched 532-nm Nd: YAG laser trabeculoplasty (selective laser trabeculo- plasty) A multicenter, pilot, clinical study. Ophthalmology 1998;105:2082-8.
  16. Popiela G, Muzyka M, Szelepin L, et al. Use of YAG-Selecta laser and argon laser in the treatment of open angle glauco- ma. Klin Oczna 2000;102:129-33.
  17. Van de Veire S, Zeyen T, Stalmans I. Argon versus selective laser trabeculoplasty. B